Home/Filings/4/0001231977-12-000069
4//SEC Filing

DUBIN THOMAS I H 4

Accession 0001231977-12-000069

CIK 0000899866other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 4:15 PM ET

Size

7.1 KB

Accession

0001231977-12-000069

Insider Transaction Report

Form 4
Period: 2012-08-23
DUBIN THOMAS I H
SVP & General Counsel
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2012-08-23$103.09/sh24,328$2,507,97474,905 total
  • Sale

    Common Stock, par value $.0001 per share

    2012-08-23$103.87/sh9,200$955,60465,705 total
Footnotes (3)
  • [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $102.65 - $103.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $103.66 - $104.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeother

Related Parties

1
  • filerCIK 0001231945

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:15 PM ET
Size
7.1 KB